awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28082572-1D4FFF3F-8899-46D6-8617-6A2E2AD7982E
Q28082572-1D4FFF3F-8899-46D6-8617-6A2E2AD7982E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28082572-1D4FFF3F-8899-46D6-8617-6A2E2AD7982E
Siltuximab (CNTO 328): a promising option for human malignancies
P2860
Q28082572-1D4FFF3F-8899-46D6-8617-6A2E2AD7982E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28082572-1D4FFF3F-8899-46D6-8617-6A2E2AD7982E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
92ff74a74dc3b2ce9e19a6421d1f8bdc353bcd42
P2860
Targeted inhibition of interleukin-6 with CNTO 328 sensitizes pre-clinical models of multiple myeloma to dexamethasone-mediated cell death.